Unity Health Toronto clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

   Primary completion pushed from Jan 2027 to Jan 2028

   Also in this update: Enrollment closed, study ongoing; Completion pushed from Jan 2027 to Jun 2028

   Unity Health Toronto·Phase 2· NCT06386003· Registry history of NCT06386003 on ClinicalTrials.gov (opens the registry)

   Updated Oct 6, 2026

2. Notable

   EpiDOSE · Epinephrine Dose: Optimal Versus Standard Evaluation…EpiDOSE · Epinephrine Dose: Optimal Versus Standard Evaluation Trial

   Primary completion pushed from Dec 2027 to Dec 2028

   Also in this update: Enrollment reduced: 3790 → 1250 participants

   Unity Health Toronto·Phase 4· NCT03826524· Registry history of NCT03826524 on ClinicalTrials.gov (opens the registry)

   Updated Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.